Björn Larsson new CEO of RLS Global
The Board of Directors of RLS Global AB (publ) has today appointed Björn Larsson as new CEO. Björn Larsson, who joins the company from Observe Medical ASA, will assume the role of CEO on 1 October.Björn Larsson has solid experience from the global medical device and pharmaceutical industry where he has held various positions in companies such as ABIGO Medical AB and AstraZeneca.“I look forward to leading the company into the next phase and, together with the board and the team, realizing the potential of RLS' unique, patented hypochlorite platform, ChloraSolv. With my experience in the